EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis

Amany Mohammed Mohmmed Hegab, Soha Osama Hassanin iD, Reham Hassan Mekky iD, Samah Sulaiman Abuzahrah, Alaaeldin Ahmed Hamza iD, Iman M Talaat iD, Amr Amin iD

Pharmaceuticals · 12.02.2025 · 18 (2) · 248

DOI: 10.3390/ph18020248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 12.02.2025. Verfasst von Amany Mohammed Mohmmed Hegab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Pharmacology and Acute Toxicity Department, Egyptian Drug Authority (EDA), Formerly National Organization of Drug Control and Research …. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sharjah’s Seed.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxorubicin (DOX) is a very powerful chemotherapy drug. However, its severe toxicity and potential for resistance development limit its application. Withania somnifera L. Dunal (WIT) has therapeutic capacities, including anti-inflammatory, antioxidant, and anticancer activities. This study investigates the preventative benefits of a standardized WIT extract against DOX-induced renal damage in vivo. We also investigate the synergistic effects of combining WIT and DOX to improve therapeutic efficacy in breast cancer cells (MCF7-ADR).

Methods

This study employed an animal model where rats were administered 300 mg/kg/day of WIT orally for a duration of 14 days. Rats received DOX injections at a dose of 5 mg/kg, for a total of 15 mg, on the 6th, 8th, and 10th days.

Results

Present results revealed that WIT reduced DOX-induced increase levels of blood urea and creatinine and the activity of kidney injury molecule-1. WIT also reduced renal tissue damage, oxidative stress, and levels of pro-inflammatory markers. WIT alleviated the effects of DOX on nuclear factor erythroid 2-related factor 2, heme oxygenase-1, and sirtuin 1 in the renal tissues. WIT modulated nuclear factor-κB activity and decreased apoptotic indicators. Furthermore, WIT improves DOX’s capacity to kill drug-resistant MCF7-ADR cells by arresting the cell cycle and promoting apoptosis. Chemical analysis of WIT root extract revealed 34 distinct compounds, including alkaloids, withanolides, flavanones, and fatty acids.

Conclusions

These constituents synergistically contribute to WIT’s antioxidant, anti-inflammatory, and anti-apoptotic properties. In addition, they confirm its ability to reduce systemic toxicity while improving treatment efficacy.

Schlagwörter

Stichwörter der Autor:innen

Withania somniferaanti-inflammatorydoxorubicinnephrotoxicityoxidative stresstherapeutic efficacy

Autor:innen und Institutionen

  • Developmental Pharmacology and Acute Toxicity Department, Egyptian Drug Authority (EDA), Formerly National Organization of Drug Control and Research (NODCAR), Giza 12611, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Modern University for Technology and Information, Cairo 11585, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo-Suez Road, Cairo 11829, Egypt.
  • Samah Sulaiman Abuzahrah, Department of Biological Sciences, College of Science, University of Jeddah, Jeddah 21959, Saudi Arabia.
  • Biology Department, Egyptian Drug Authority (EDA), Formerly National Organization of Drug Control and Research (NODCAR), Giza 12611, Egypt.
  • Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.

ORCID-Profile: Soha Osama Hassanin, Reham Hassan Mekky, Alaaeldin Ahmed Hamza, Iman M Talaat, Amr Amin

Förderung

  • University of Sharjah’s Seed

Zitieren

APA

Mohmmed Hegab, A. M., Hassanin, S. O., Mekky, R. H., Abuzahrah, S. S., Hamza, A. A., Talaat, I. M., & Amin, A. (2025). Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals, 18(2), 248. https://doi.org/10.3390/ph18020248

Vancouver

Mohmmed Hegab AM, Hassanin SO, Mekky RH, Abuzahrah SS, Hamza AA, Talaat IM, et al. Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceuticals. 2025;18(2):248. doi:10.3390/ph18020248

BibTeX
@article{MohmmedHegab2025,
  author = {Mohmmed Hegab, Amany Mohammed and Hassanin, Soha Osama and Mekky, Reham Hassan and Abuzahrah, Samah Sulaiman and Hamza, Alaaeldin Ahmed and Talaat, Iman M and Amin, Amr},
  title = {Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {2},
  pages = {248},
  doi = {10.3390/ph18020248}
}
Kostenlos starten →